Kelderman Kim (CIK 0001739054)

Latest company ownership

Shares held
801,711
Last filed at
Nov 5, 2025
Confidence Score
19.5
2025Q4
Confidence Score History
2019Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 3, 2025 Nov 5, 2025 BIO-TECHNE Corp CEO Sell 22.5 -2,303 -4.52% $144.1K
Aug 15, 2025 Aug 19, 2025 BIO-TECHNE Corp CEO Sell 22.5 -4,305 -7.79% $230.7K
Jul 22, 2025 Jul 24, 2025 BIO-TECHNE Corp CEO Sell 17.5 -43,649 -48.30% $2.3M
Jul 15, 2025 Jul 17, 2025 BIO-TECHNE Corp CEO Sell 17.5 -32,933 -43.83% $1.7M
Jan 27, 2025 Jan 29, 2025 BIO-TECHNE Corp CEO Sell 17.5 -13,392 -25.56% $1M
Nov 1, 2024 Nov 5, 2024 BIO-TECHNE Corp CEO Sell 22.5 -2,430 -5.86% $183K
Jul 31, 2024 Aug 2, 2024 BIO-TECHNE Corp CEO Sell 20.0 -9,479 -19.18% $777K
Aug 5, 2023 Aug 8, 2023 BIO-TECHNE Corp Pres. Diagnostics & Genom Sell 20.0 -4,139 -17.79% $340.1K
Aug 7, 2022 Aug 9, 2022 BIO-TECHNE Corp Pres. Diagnostics & Genom Sell 20.0 -1,214 -27.90% $464.9K
Nov 19, 2021 Nov 23, 2021 BIO-TECHNE Corp Pres. Diagnostics & Genom Sell 20.0 -500 -100.00% $252.7K
Sep 22, 2021 Sep 24, 2021 BIO-TECHNE Corp Pres. Diagnostics & Genom Sell 7.5 -822 -100.00% $434.9K
Aug 8, 2021 Aug 10, 2021 BIO-TECHNE Corp Pres. Diagnostics & Genom Sell 20.0 -869 -51.39% $418.7K
Jun 9, 2021 Jun 11, 2021 BIO-TECHNE Corp Pres. Diagnostics & Genom Sell 20.0 -811 -100.00% $351.2K
May 25, 2021 May 27, 2021 BIO-TECHNE Corp Pres. Diagnostics & Genom Sell 20.0 -845 -51.03% $358.3K
May 1, 2021 May 4, 2021 BIO-TECHNE Corp Pres. Diagnostics & Genom Sell 20.0 -856 -34.08% $365.9K
Feb 5, 2021 Feb 9, 2021 BIO-TECHNE Corp Pres. Diagnostics & Genom Sell 20.0 -823 -49.34% $319.7K
May 1, 2020 May 5, 2020 BIO-TECHNE Corp Pres. Diagnostics & Genom Sell 22.5 -821 -32.99% $186.8K
May 1, 2019 May 2, 2019 BIO-TECHNE Corp President Sell 22.5 -844 -50.63% $170.6K